Media

Filter by Category

All Blog News Newsletters Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

Tucson-based Critical Path Institute emerging as top drug-research organization

President and CEO Dr. Martha Brumfield was recently interviewed by the Arizona Daily Star for a profile on C-Path published Februa

Critical Path to TB Drug Regimens (CPTR) 2018 Annual Workshop, postponed

Critical Path Institute and Bill & Melinda Gates Foundation have decided to postpone the Critical Path to TB Drug Regimens Wor

January 22, 2018

Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort

Critical Path Institute Receives Regulatory Support for Liver Injury Biomarker

Tucson, AZ — January 22, 2018 — Critical Path Institute (C-Path) announced today that the European Medicines Agency (E

C-Path welcomes Kay Holcombe to its Board of Directors

January 17, 2018 TUCSON, Ariz., January 17, 2018 — The Critical Path Institute (C-Path) is pleased to welcome Kay Holcombe to i

January 1, 2018

Development of a symptom-focused patient-reported outcome measure for functional dyspepsia: the Functional Dyspepsia Symptom Diary (FDSD)

Performance Assessment of New Urinary Translational Safety Biomarkers of Drug-induced Renal Tubular Injury in Tenofovir-treated Cynomolgus Monkeys and Beagle Dogs

Individual serum bile acid profiling in rats aids in human risk assessment of drug-induced liver injury due to BSEP inhibition

December 22, 2017

A Dynamic Map for Learning, Communicating, Navigating and Improving Therapeutic Development

December 22, 2017

Application of a Dynamic Map for Learning, Communicating, Navigating, and Improving Therapeutic Development

Previous7778 79...125 Next